Clinical Trials

1 enrolled

Infections, Lymphoma

NCT05923879 2023-06-28

Mechanism Investigation of Selinexor Combined With Lenalidomide and Rituximab in the Treatment of Diffuse Large B-cell Lymphoma

30 enrolled

Lymphoma, Large B-Cell, Diffuse

NCT02536664 2023-04-18

Non-Interventional Study to Examine Rituximab Treatment in Follicular Lymphoma Participants

505 enrolled 11 charts

Lymphoma, Follicular

NCT05690191 2023-01-19

Chidamide in Patients With Recurrent and Refractory Diffuse Large b

Enrolling by invitation

169 enrolled

Lymphoma, Large B-Cell, Diffuse

NCT03545035 2022-05-12

LLC178

104 enrolled

Leukemia, Lymphocytic, Chronic, B-Cell

NCT03289182 2021-01-11

An Observational Study of MabThera Subcutaneous (SC) Safety in Participants With Non-Hodgkin's Lymphoma (NHL) or Chronic Lymphocytic Leukemia (CLL)

701 enrolled

Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell

NCT02491398 2020-10-06

LLC1315

494 enrolled

Leukemia, Lymphocytic, Chronic, B-Cell

NCT04127916 2020-03-18

Bendamustine Plus Rituximab for Mantle Cell Lymphoma: a Multicenter Retrospective Analysis(BR-MCL)

40 enrolled

Lymphoma, Mantle-Cell

NCT03582098 2019-04-12

RETRO-idel

112 enrolled

Leukemia, B-Cell

NCT01178086 2018-10-05

A Study on Rituximab (MabThera) in Participants With Chronic Lymphocytic Leukemia (CLL)

681 enrolled 14 charts

Leukemia, Lymphocytic, Chronic, B-Cell

NCT01609023 2018-06-26

CaLLypso

67 enrolled 10 charts

Leukemia, Lymphocytic, Chronic, B-Cell

NCT02732236 2018-04-18

Marginal Zone Lymphoma Cohort in Korea

500 enrolled

Lymphoma, B-Cell, Marginal Zone

NCT02654379 2018-04-09

Observational Study Evaluating Rituximab Use and Use of the Patient Alert Card in Participants Receiving Rituximab Infusion for a Non-Oncology Indication at Infusion Centers in Europe

1,408 enrolled

Off-Label Use

NCT01684865 2017-12-29

An Observational Study of First-Line Maintenance Rituximab (MabThera/Rituxan) in Participants With Follicular Non-Hodgkin's Lymphoma

22 enrolled

Lymphoma, Non-Hodgkin

NCT02472756 2017-08-01

REFLECT 2

41 enrolled 7 charts

Lymphoma, Follicular

NCT01406782 2017-05-17

DNA Analysis in Influencing Response to Rituximab in Samples From Patients With Follicular Lymphoma Treated on ECOG-E4402

200 enrolled

Lymphoma, Lymphoma, Follicular

NCT01224093 2016-11-02

An Observational Study on the Safety Profile of MabThera/Rituxan (Rituximab) in Combination With Chemotherapy in Patients With B Cell-lineage Chronic Lymphocytic Leukaemia (MABERYC)

219 enrolled

Leukemia, Lymphocytic, Chronic, B-Cell

NCT01072240 2016-11-01

An Observational Study on Infusion-related Adverse Events at Administration of MabThera (Rituximab) in Patients With Chronic Lymphocytic Leukemia

92 enrolled

Leukemia, Lymphocytic, Chronic, B-Cell

NCT01613027 2016-10-24

An Observational Study of MabThera in Participants With Severe Active Rheumatoid Arthritis

135 enrolled 21 charts

Arthritis, Rheumatoid

NCT01641952 2016-08-17

An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Rheumatoid Arthritis and an Inadequate Response or Intolerance to One Anti-Tumor Necrosis Factor (Anti-TNF) Agent

505 enrolled 15 charts

Arthritis, Rheumatoid

NCT01144754 2016-07-01

Observational Study of Diffuse Large B Cell Primary Breast Lymphomas Treated With RCHOP +/- XRT

Terminated

1 enrolled

Lymphoma, Lymphoma, Non-Hodgkin

NCT02316613 2016-02-25

Prospective Observational Study on the Management of Patients With Relapsed or Refractory Follicular Lymphoma (OLYMPE)

260 enrolled 25 charts

Lymphoma, Follicular

NCT02461290 2015-09-30

Rituximab Therapy in Follicular Lymphoma in Combination With Chemotherapy - REFLECT 1

99 enrolled 9 charts

Lymphoma, Follicular

NCT02156726 2014-06-05

Q-lite

200 enrolled

Leukemia, Lymphocytic, Chronic, B-Cell

NCT00301301 2010-01-12

A Retrospective Review of Gemcitabine, Methylprednisolone Cisplatin (GEM-P) With or Without Rituximab in Patients With Relapsed/Refractory Diffuse Large B Cell Lymphoma (DLBCL)

39 enrolled

Lymphoma, Non-Hodgkin

NCT00429065 2007-01-31

Treatment of Good Prognosis, BCL-6 Negative Diffuse Large Cell Lymphoma With CHOP-R in Patients < 61 Years Old.

30 enrolled